HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services, with a "1+2+3+4=1" service system enabling supply of original factory Bis(benzonitrile)palladium(II) Chloride from multiple renowned brands.
With over a decade of market experience and deep technological transformation cooperation with manufacturers, HiSiaddi possesses extensive expertise resolving product compliance issues. Below is a case detailing HiSiaddi’s handling of regulatory compliance challenges for Bis(benzonitrile)palladium(II) Chloride.
Please contact HiSiaddi customer service to inquire about additional regulatory compliance issues for Bis(benzonitrile)palladium(II) Chloride.
PharmaNova AG, based in Zurich, Switzerland, is a high-end API enterprise specializing in mass production and clinical R&D of targeted anti-tumor APIs. Bis(benzonitrile)palladium(II) Chloride (CAS: 14220-64-5) serves as the core precious metal catalyst for Suzuki cross-coupling reactions, with an annual procurement volume of 320kg, previously sourced from Merck imported reagent-grade products for years.
Faced with surging European precious metal raw material prices and tight overseas lead times, the client selected domestically manufactured pharmaceutical-grade goods from a leading domestic manufacturer for an initial 85kg trial order, entrusting the domestic factory to arrange export independently. Upon arrival at Hamburg transit port, Germany, the cargo was detained by EU customs due to four compliance defects, risking return shipment, heavy port detention fines, and suspended API production line commissioning. The client urgently commissioned HiSiaddi to oversee full-process compliance rectification, supplementary certification acquisition, and secondary customs clearance for release.
The client faced three inherent dilemmas: Domestic manufacturers only focus on product manufacturing with limited familiarity with EU REACH, CLP, Swiss pharmaceutical access, and marine hazardous goods regulations; the Swiss pharmaceutical enterprise lacks an in-house Chinese chemical export compliance team, with no understanding of domestic customs clearance, hazardous goods packaging, testing, and EU local regulatory representative rules. Independent rectification was projected to take 45 days, with daily production line downtime losses exceeding 20,000 EUR.
The original manufacturer supplied an outdated 12-section MSDS instead of the EU-standard 16-chapter SDS format. Critical omissions included a local EU 24-hour chemical emergency contact number, UFI unique formulation identifier, and SVHC Substance of Very High Concern screening statements. Component concentrations of benzonitrile and chloride ions were ambiguously labeled without distinguishing free ligands versus coordinated active components, violating CLP chemical classification labeling standards, resulting in rejection by EU customs.
Annual import volume of Bis(benzonitrile)palladium(II) Chloride exceeds 1 ton. Per ECHA regulations, non-EU overseas manufacturers must appoint a local EU Only Representative to complete REACH tonnage notification. The original supplier failed to fulfill this requirement, with no registration dossiers or notification receipts—this mandatory EU import entry qualification gap constituted the primary reason for customs detention.
The manufacturer’s original CoA only reported total palladium content without testing four strictly controlled heavy metals (As, Pb, Hg, Cd), free benzonitrile residues, free chloride ions, or solvent residuals. Swiss pharmaceutical authorities mandate catalyst impurities comply with ICH Q3D guidelines for API auxiliary materials; the existing report was inadmissible for Swiss drug review, rendering the cargo unusable for production even if cleared through customs.
The pale yellow crystalline powder was packed in ordinary plastic drums without UN hazard classification numbers, official hazardous goods performance classification appraisals, or valid hazardous goods packaging use certificates. Classified as Class 9 environmentally hazardous chemicals under IMDG, the cargo lacked official packaging compliance paperwork, leading ocean carriers to refuse transshipment to Switzerland and resulting in port detention.
1. Collaborate with authoritative domestic chemical laboratories to compile a 16-chapter standard English SDS aligned with REACH Annex II (EU2020/878), accurately listing CAS numbers, EC numbers, precise concentration limits for all components, hazard classifications, and storage & transportation protection guidelines;
2. Entrust EU local regulatory institutions to apply for UFI formulation identification codes, conduct full-component SVHC Substance of Very High Concern screening, and issue third-party screening reports. The revised SDS prominently displays a local EU 24-hour emergency contact on the front page, replacing the original invalid documentation set.
Leveraging long-term cooperative German regulatory institutions, HiSiaddi signed a locally certified EU Only Representative on behalf of the domestic manufacturer. We organized product physicochemical data, toxicology reports, and annual production & sales volumes to submit a 320kg annual import tonnage pre-notification to ECHA, obtaining official REACH acceptance receipts and notification numbers to fill the mandatory EU import entry qualification gap.
1. HiSiaddi coordinated port-side sampling of detained cargo for full testing at SGS laboratories, covering effective palladium content, free chloride ions, free benzonitrile, heavy metals (As/Cd/Hg/Pb), organic solvent residuals, and particle size distribution, with all indicators benchmarked against Swiss EP Pharmacopoeia and ICH Q3D elemental impurity limits;
2. Issue trilingual Chinese-English-German CoA quality inspection reports with laboratory qualification statements attached, satisfying both EU customs clearance audits and Swiss pharmaceutical factory drug filing registration requirements.
1. On-site packaging renovation within Hamburg bonded warehouse: Inner vacuum aluminum foil hermetic sealing + intermediate explosion-proof plastic drums + outer rust-proof iron drums, with CLP-compliant hazardous goods warning labels and UN numbers affixed to each drum;
2. Expedite domestic exit hazardous goods transport packaging use certificates and hazardous goods classification appraisal documents simultaneously, updating customs declaration elements and HS code (28439090 Precious Metal Coordination Compounds). Standardize declared product names, compositions, applications, and content to ensure full data consistency across bills of lading, commercial invoices, packing lists, and customs filings.
1. Full compliance rectification completed within 18 days: The revised full set of regulatory documentation was submitted to Hamburg Customs for secondary review. After verifying compliant SDS, REACH notification receipts, SGS test reports, and hazardous goods transport paperwork, customs lifted detention orders. Cargo was transshipped from Germany to the client’s Zurich, Switzerland facility;
2. Client feeding verification: Upon warehouse receipt, the client conducted full re-inspection confirming all impurity and catalytic indicators matched Merck imported standards. The cargo was successfully integrated into API production lines, maintaining cross-coupling yields above 93% and enabling on-schedule production line commissioning;
3. Formal annual 320kg framework procurement contract signed: The client locked in annual bulk purchasing split into 6 monthly shipments. HiSiaddi conducts pre-approval of full compliance documentation, pre-filing REACH notifications, and verification of hazardous goods packaging & SDS for every batch to eliminate recurrences of customs detention risks. Localized comprehensive procurement costs decreased by 31% versus original imported materials.
1. Industry Regulatory Pain Points: Domestic catalyst manufacturers prioritize mass production with limited reserves of EU chemical regulatory and national pharmacopoeia compliance expertise, only capable of issuing basic factory delivery documents. European and American high-end pharmaceutical enterprises face dual regulatory constraints from national drug authorities and customs; minor defects in catalyst compliance documentation trigger cargo detention and production line shutdowns, creating substantial regulatory information barriers between supply and demand sides.
2. HiSiaddi Core Value: We operate a closed-loop full-chain compliance service spanning domestic manufacturers, third-party testing laboratories, EU regulatory institutions, international ocean freight, and overseas customs clearance, delivering one-stop resolution of four core compliance categories: REACH registration, SDS documentation, pharmacopoeia testing, and hazardous goods packaging. Our comprehensive compliance service secures long-term stable cooperation with high-end Swiss clients. Leveraging regulatory resources established via this project, we subsequently undertook export compliance services for two equivalent pharmaceutical enterprises in Austria and Denmark requiring Bis(benzonitrile)palladium(II) Chloride.
Please contact HiSiaddi customer service to inquire about additional regulatory compliance issues for Bis(benzonitrile)palladium(II) Chloride.
+86-13120989737 
info@hisiaddi.com 
English
